4.8 Review

The Role of Non-coding RNAs in Oncology

Journal

CELL
Volume 179, Issue 5, Pages 1033-1055

Publisher

CELL PRESS
DOI: 10.1016/j.cell.2019.10.017

Keywords

-

Funding

  1. NIH-YALE SPORE in Lung Cancer [P50CA196530]
  2. NCI Outstanding Investigator Award [R35CA231996, R35CA232105]
  3. Ludwig Center at Harvard
  4. Lungevity Foundation
  5. V Foundation for Cancer Research
  6. NCI Prostate SPORE [P50CA186786]
  7. Prostate Cancer Foundation
  8. Early Detection Research Network [UO1CA214170]
  9. [P50CA196530-03S1]
  10. [R01CA212649]

Ask authors/readers for more resources

For decades, research into cancer biology focused on the involvement of protein-coding genes. Only recently was it discovered that an entire class of molecules, termed non-coding RNA (ncRNA), plays key regulatory roles in shaping cellular activity. An explosion of studies into ncRNA biology has since shown that they represent a diverse and prevalent group of RNAs, including both oncogenic molecules and those that work in a tumor suppressive manner. As a result, hundreds of cancer-focused clinical trials involving ncRNAs as novel biomarkers or therapies have begun and these are likely just the beginning.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available